92 results on '"Kudlinzki D"'
Search Results
2. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATDL11
3. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT058
4. Crystal Structure of Farnesoid X receptor (FXR) with bound NCoA-2 peptide and CDCA
5. Crystal Structure of Farnesoid X receptor (FXR) with bound NCoA-2 peptide
6. Crystal Structure of Ephrin B4 (EphB4) Receptor Protein Kinase with a pyrazolo[3,4-d]pyrimidine fragment of NVP-BHG712
7. Crystal Structure of Ephrin B4 (EphB4) Receptor Protein Kinase with Dasatinib
8. Crystal Structure of Ephrin B4 (EphB4) Receptor Protein Kinase
9. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with a pyrazolo[3,4-d]pyrimidine fragment of NVP-BHG712
10. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with an isomer of NVP-BHG712
11. Crystal Structure of Ephrin B4 (EphB4) Receptor Protein Kinase with an isomer of NVP-BHG712
12. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with NVP-BHG712
13. Crystal Structure of Ephrin B4 (EphB4) Receptor Protein Kinase with NVP-BHG712
14. Impact of IR active probes on PDZ3 and its ligand binding studied by NMR and X-ray crystallography
15. Crystal Structure of the third PDZ domain from the synaptic protein PSD-95 with incorporated Azidohomoalanine
16. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 3d
17. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2g
18. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 4a
19. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 1l
20. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with AGS
21. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with danusertib (PHA739358)
22. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with golvatinib (E7050)
23. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with MLN8054
24. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with compound 66
25. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with dasatinib
26. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with bosutinib (SKI-606)
27. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with PD173955
28. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with alisertib (MLN8237)
29. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase
30. Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with foretinib (XL880)
31. Crystal structure of Gamma-B Crystallin expressed in E. coli based on mRNA variant 1
32. Crystal structure of Gamma-B Crystallin expressed in E. coli based on mRNA variant 2
33. FXR with CDCA and NCoA-2 peptide
34. FXR with DM175 and NCoA-2 peptide
35. Crystal structure of SAH-bound Podospora anserina methyltransferase PaMTH1
36. Apo-crystal structure of Podospora anserina methyltransferase PaMTH1
37. Crystal structure of cAMP-dependent Protein Kinase A from Cricetulus griseus
38. Low resolution crystal structure of the FGFR2D2D3/FGF1/SR128545 complex
39. Crystal Structure Analysis of a helicase associated domain
40. Crystallographic studies on molecular motors and switches of the spliceosome
41. Optimization of the Lead Compound NVP-BHG712 as a Colorectal Cancer Inhibitor.
42. Cysteine oxidation and disulfide formation in the ribosomal exit tunnel.
43. Identification of Eph receptor signaling as a regulator of autophagy and a therapeutic target in colorectal carcinoma.
44. Molecular tuning of farnesoid X receptor partial agonism.
45. On the Implication of Water on Fragment-to-Ligand Growth in Kinase Binding Thermodynamics.
46. NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.
47. Modulation of the Allosteric Communication between the Polo-Box Domain and the Catalytic Domain in Plk1 by Small Compounds.
48. Paradoxically, Most Flexible Ligand Binds Most Entropy-Favored: Intriguing Impact of Ligand Flexibility and Solvation on Drug-Kinase Binding.
49. Impact of Azidohomoalanine Incorporation on Protein Structure and Ligand Binding.
50. Chemoproteomics-Aided Medicinal Chemistry for the Discovery of EPHA2 Inhibitors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.